drugset / Trial / NCT00408785
A Study Of BOTOX For The Treatment Of Glabellar Lines
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a Multicenter, double-blind, randomized, placebo-controlled, parallel-group comparative study to confirm the efficacy and safety of BOTOX 20 units single injection for the Chinese patients with glabellar lines. The subjects will receive a single intramuscular treatment consisting of 5 injections of either BOTOX? 20U or placebo.
Timeline
- Start
- 2006-11-01
- Primary completion
- 2007-05-09
- Completion
- 2007-05-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 20 iu | Intramuscular |
Indications
No indication recorded.